Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00231972 · ClinicalTrials.gov registry record · NA

Enhancing HIV Prevention by Using Behavioral Intervention Among HIV-Infected Men

A NA study of HIV Infections, sponsored by Fenway Community Health.

Completed
Registry status
NA
Development phase
201
Enrollment target
1
Study location

NCT00231972: Completed NA study of HIV Infections, sponsored by Fenway Community Health.

NCT00231972 is a NA study of HIV Infections that has completed, run by Fenway Community Health. The registered enrollment target is 201 participants, below the 445-participant average among 542 other HIV Infections trials with a reported enrollment target (55% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00231972, a NA study of HIV Infections, has completed, sponsored by Fenway Community Health.

COMPLETED
Registry status
NA
Development phase
201 participants
Enrollment target
1
Study location

Study Summary

This study will evaluate the effectiveness of a behavioral intervention program versus standard prevention case management in promoting safer sex practices in HIV-infected men.

Conditions Studied

Interventions

  • BEHAVIORAL Project Enhance
  • BEHAVIORAL Standard prevention case management (PCM)

Study Locations (1)

Massachusetts

  • Fenway Community Health - Boston

Trial Details

FieldValue
Enrollment Target 201 participants
Start Date 2003-12
Est. Completion 2008-07
Phase NA
Fenway Community Health

14 total trials

What the finished NCT00231972 record still lists

NCT00231972 is an interventional study that assigns participants to a tested intervention. The registered 201 participants enrollment target is mid-sized for trials with a published cap, below the 445-participant average among 542 other HIV Infections trials with a reported enrollment target (55% lower).

The record links to 1 condition, with HIV Infections appearing as the primary indexed condition, and to 2 interventions - of which Project Enhance is the first listed.

NCT00231972 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT00231972 about?

NCT00231972 is a clinical study titled "Enhancing HIV Prevention by Using Behavioral Intervention Among HIV-Infected Men". This study will evaluate the effectiveness of a behavioral intervention program versus standard prevention case management in promoting safer sex practices in HIV-infected men.

What is the current status of trial NCT00231972?

This trial is currently completed. It is a NA study. The enrollment target is 201 participants. The study started on 2003-12. Estimated completion is 2008-07.

What conditions does trial NCT00231972 study?

This clinical trial studies the following conditions: HIV Infections.

What interventions are being tested in trial NCT00231972?

The interventions under investigation include: Project Enhance (BEHAVIORAL), Standard prevention case management (PCM) (BEHAVIORAL).

Who is sponsoring clinical trial NCT00231972?

This trial is sponsored by Fenway Community Health, which has 14 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00231972 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for HIV Infections

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00231972's enrollment target sits among peer trials

201 170th of 542 higher than 373 of 542 other HIV Infections trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other HIV Infections trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04422652 · 201 participants · Phase 2

    Combination of Novel Therapies for CKD Comorbid Depression

  • NCT05327114 · 201 participants · Phase 2

    Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

  • NCT06099769 · 201 participants · Phase 2

    A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast Cancer

  • NCT06274528 · 201 participants · Phase 2

    DORA and LP in Alzheimer's Disease Biomarkers

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00231972, the US trial registry maintained by the National Library of Medicine. NCT00231972 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.